These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 6138990

  • 21. [Gene engineering EB virus membrane antigen in detection of MA-IgA antibody--comparison with VCA-IgA and EA-IgA antibodies].
    Liu MZ.
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):288-90. PubMed ID: 2176967
    [Abstract] [Full Text] [Related]

  • 22. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [Abstract] [Full Text] [Related]

  • 23. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W, Cao SM, Huang QH, Li YH, Deng MQ.
    Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
    [Abstract] [Full Text] [Related]

  • 24. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
    Gong SH, Lynn TC, Yang CS.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):8-15. PubMed ID: 211015
    [Abstract] [Full Text] [Related]

  • 25. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW.
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression].
    Cai YL, Zheng YM, Cheng JR, Li J, Mo YK, Zhong QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM.
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [Abstract] [Full Text] [Related]

  • 28. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [Abstract] [Full Text] [Related]

  • 29. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 Jul; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 30. Presence of Epstein-Barr virus DNA in tonsillar tissues.
    Brichácek B, Suchánková A, Hirsch I, Síbl O, Rezácova D, Závadová H, Vonka V.
    Acta Virol; 1981 Nov; 25(6):361-70. PubMed ID: 6120637
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
    Puthavathana P, Kositanont U, Chongkolwatana C, Metheetrairut C, Chantarakul N, Nuntarakchaikul S, Wasi C.
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
    [Abstract] [Full Text] [Related]

  • 32. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
    Luo YL, Ou GP, Chi PD, Liang YN, Liu YH, Huang MY.
    Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423
    [Abstract] [Full Text] [Related]

  • 33. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH, Soo MY, Gan YY, Fones-Tan A, Sim PS, Kaur A, Chew CT.
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [Abstract] [Full Text] [Related]

  • 34. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.
    Anticancer Res; 2001 Jun; 21(4B):3021-9. PubMed ID: 11712805
    [Abstract] [Full Text] [Related]

  • 35. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M, Rezbová M, Svecová M, Hrbácková H, Novotná M, Ochotná J, Roubalová K.
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [Abstract] [Full Text] [Related]

  • 36. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
    Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
    [Abstract] [Full Text] [Related]

  • 37. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 38. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH.
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [Abstract] [Full Text] [Related]

  • 39. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T.
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [Abstract] [Full Text] [Related]

  • 40. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.